AHF Pushes SF Drug Pricing Measure
The Los Angeles-based AHF is sponsoring a ballot measure this fall to encourage San Francisco officials to call for cheaper drug prices.
According to the measure’s title and summary, San Francisco purchases prescription drugs for city-run medical programs and spends over $23 million a year on prescription drugs. That includes about $3.5 million annually for antiretroviral medications for inpatients with HIV and related conditions.
In a May 28 email exchange, Yeghiayan said, "We are looking forward to the vote in November."
AHF needed to gather 9,703 valid signatures to get the measure on the fall ballot and started the collection last November. In a statement dated March 1, the agency said the measure had qualified as it gathered 17,800 signatures from San Francisco residents.
"We are thrilled to have formal notice that our prescription drug purchasing initiative has qualified for the ballot," AHF President Michael Weinstein was quoted as saying. "As government programs pay for the vast majority of drug purchases in this country, we believe a state as vast and powerful as California - and a city and county like San Francisco - can and should use its clout to stand up to and rein in runaway pricing of drug companies. That is why we are now taking this issue directly to the people of San Francisco in November through this ballot measure."
The press release also quoted Board of Supervisors President David Chiu as "look(ing) forward" to helping pass the measure.